Atea Pharmaceuticals Inc. (AVIR) NASDAQ

$4.07 0.07 (1.62%)

Market Cap: $336.66M

As of 03/28/24 01:54 PM EDT. Market open.

(AVIR)

Atea Pharmaceuticals Inc. (AVIR)
NASDAQ

$4.07
0.07 (1.62%)

Market Cap: $336.66M

As of 03/28/24 01:54 PM EDT. Market open.

Add to Portfolio

atea pharmaceuticals, inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for severe viral diseases. the company's lead product candidate is at-527, a novel antiviral agent for the treatment of patients infected with severe acute respiratory syndrome coronavirus 2 and is under phase 3 clinical trial. it also develops at-787 which is under phase 2 clinical for the ... read more

atea pharmaceuticals, inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for severe viral diseases. the company's lead product candidate is at-527, a novel antiviral agent for the treatment of patients infected with severe acute respiratory syndrome coronavirus 2 and is under phase 3 clinical trial. it also develops at-787 which is under phase 2 clinical for the treatment of hepatitis c virus; at-752 which is under phase 2 clinical trial for the treatment of dengue; and at-889, at-934, and other product candidates for the treatment of respiratory syncytial virus are under phase 2 clinical trials. the company was incorporated in 2012 and is based in boston, massachusetts. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
60
Address
.
PRICE CHART FOR ATEA PHARMACEUTICALS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$4.01
Previous Close
$4
Days Range
$3.88 - $4.05
52 week range
$2.77 - $5.19
Volume
94,574
Avg. Volume (30 days)
438,153
Market Cap
$336.66M
Dividend Yield
-
P/E
-
Shares Outstanding
84,164,545
Open
$4.01
Previous Close
$4
Days Range
$3.88 - $4.05
52 week range
$2.77 - $5.19
Volume
94,574
Avg. Volume (30 days)
438,153
Market Cap
$336.66M
Dividend Yield
-
P/E
-
Shares Outstanding
84,164,545
FINANCIAL STATEMENTS FOR ATEA PHARMACEUTICALS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ATEA PHARMACEUTICALS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Corcoran AndreaSee RemarksFeb 01, 2024 Sale$3.8415,84360,915670,208Feb 02, 2024, 09:31 PM
Sommadossi Jean-PierrePresident, CEO, and ChairmanFeb 01, 2024 Sale$3.8556,910218,819116,557Feb 02, 2024, 09:30 PM
Horga Maria ArantxaChief Medical OfficerFeb 01, 2024 Sale$3.8415,87060,96325,664Feb 02, 2024, 09:29 PM
Foster WayneEVP, Chief Accounting OfficerFeb 01, 2024 Sale$3.8412,47747,90420,857Feb 02, 2024, 09:26 PM
Vavricka JohnChief Commercial OfficerFeb 01, 2024 Sale$3.8411,81945,42021,515Feb 02, 2024, 09:25 PM
Hammond Janet MJChief Development OfficerFeb 01, 2024 Sale$3.8414,02953,91335,362Feb 02, 2024, 09:24 PM
BERGER FRANKLIN MDirectorNov 14, 2022 Sale$5.1616,16683,352778,353Nov 15, 2022, 08:00 PM
BERGER FRANKLIN MDirectorNov 11, 2022 Sale$5.1525,500131,333794,519Nov 15, 2022, 08:00 PM
Murphy Polly A.DirectorDec 20, 2021 Buy$8.5712,000102,79623,295Dec 21, 2021, 09:41 PM
Rock Springs Capital Management LP10% OwnerNov 03, 2020 Buy$24.00250,0006,000,0001,654,724Nov 04, 2020, 04:05 PM
Hack Andrew A. F.DirectorNov 03, 2020 Buy$24.00250,0006,000,0005,615,659Nov 03, 2020, 09:36 PM
BERGER FRANKLIN MDirectorNov 03, 2020 Buy$24.0041,666999,984820,019Nov 03, 2020, 08:09 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Corcoran AndreaSee Remarks02/01/202460,915
Sommadossi Jean-PierrePresident, CEO, and Chairman02/01/2024218,819
Horga Maria ArantxaChief Medical Officer02/01/202460,963
Foster WayneEVP, Chief Accounting Officer02/01/202447,904
Vavricka JohnChief Commercial Officer02/01/202445,420
Hammond Janet MJChief Development Officer02/01/202453,913
BERGER FRANKLIN MDirector11/14/202283,352
BERGER FRANKLIN MDirector11/11/2022131,333
Murphy Polly A.Director12/20/2021102,796
Rock Springs Capital Management LP10% Owner11/03/20206,000,000
Hack Andrew A. F.Director11/03/20206,000,000
BERGER FRANKLIN MDirector11/03/2020999,984
Load More Insider Transactions
FUNDS WITH A POSITION IN ATEA PHARMACEUTICALS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.9,443,8870.00073%15.29%Other
GEODE CAPITAL MANAGEMENT, LLC1,807,9120.00058%4.76%Other
RENAISSANCE TECHNOLOGIES LLC1,496,3030.00706%10.47%Other
TYRUS CAPITAL S.A.M.1,260,00035.9%No changeEvent Driven
D. E. SHAW & CO., INC.185,1770.00049%164.73%Other
ALPS ADVISORS INC58,4360.0014%-5.09%Other
AQR CAPITAL MANAGEMENT LLC30,3530.00019%ExitedOther
CHANGE IN SHARES OUTSTANDING FOR ATEA PHARMACEUTICALS INC
STOCK BUYBACKS FOR ATEA PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.04%
1Q
12/31/2023
06/30/2023
0.04%
2Q
12/31/2023
03/31/2023
0.12%
3Q
12/31/2023
12/31/2022
0.18%
4Q
12/31/2023
09/30/2022
0.21%
5Q
12/31/2023
06/30/2022
0.21%
6Q
12/31/2023
03/31/2022
0.31%
7Q
12/31/2023
12/31/2021
-4.77%
8Q
12/31/2023
09/30/2021
0.75%
9Q
12/31/2023
06/30/2021
-5.28%
10Q
12/31/2023
03/31/2021
-6.36%
11Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.04%
1Q
06/30/2023
0.04%
2Q
03/31/2023
0.12%
3Q
12/31/2022
0.18%
4Q
09/30/2022
0.21%
5Q
06/30/2022
0.21%
6Q
03/31/2022
0.31%
7Q
12/31/2021
-4.77%
8Q
09/30/2021
0.75%
9Q
06/30/2021
-5.28%
10Q
03/31/2021
-6.36%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ATEA PHARMACEUTICALS INC
LOADING...